BTIG analyst Janine Stichter raised the firm’s price target on Warby Parker (WRBY) to $30 from $22 and keeps a Buy rating on the shares ahead ...

Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted ...

In a report released yesterday, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...

Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted that ...

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

Marine Systems, a key segment for GD, continues to face margin pressure despite robust sales growth, as supply chain ...

Rhumbline Advisers grew its holdings in MercadoLibre, Inc. (NASDAQ:MELI – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm ...

The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend BTIG’s MedTech, ...